Mounjaro

Zepbound Trumps Wegovy in Weight Loss Showdown, Study Finds

Zepbound helped patients lose more weight than Wegovy in a 72-week trial, with greater reductions in both body weight and waist size.

Shrinking Waists, Sizable Earnings: Weight-Loss Drug Market Estimated at $100 Billion by 2030

According to Barclays, the weight-loss drug industry could even climb as high as $200 billion within the next decade.